UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 9, 2006
NEWGEN TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Nevada 000- 23365 33-0840184
(State or Other Jurisdiction (Commission File (I.R.S. Employer
of Incorporation) Number) Identification Number)
6000 Fairview Road, 12th Floor, Charlotte, North
Carolina 28210 (Address of principal executive offices) (zip code)
(704) 552-3590
(Registrant's telephone number, including area code)
Copies to:
Thomas A. Rose, Esq.
Yoel Goldfeder, Esq.
Sichenzia Ross Friedman Ference LLP
1065 Avenue of the Americas
New York, New York 10018
Phone: (212) 930-9700
Fax: (212) 930-9725
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 4.02 NON-RELIANCE ON PREVIOUSLY ISSUED FINANCIAL STATEMENTS OR A RELATED
AUDIT REPORT OR COMPLETED INTERIM REVIEW.
On August 14, 2006, a Form 10-QSB/A was filed in error by the filing agent
of NewGen Technologies, Inc. ("the Company"). This document was meant for review
by the Securities and Exchange Commission ("SEC") only, and not for public
dissemination. The Company is currently attempting to have this filing removed
from the SEC's public records. Accordingly, you should not rely on any of the
information contained in this erroneous filing.
In connection with the filing of the Company's Registration Statement on
Form SB-2 ("Form SB-2") on February 10, 2006, and in the customary course of the
SEC'sreview of the Form SB-2 and our Form 10-QSB for the three month period
ended March 31, 2006, the SEC has issued a comment letter (the "Comment Letter")
to the Company. The primary focus of the Comment Letter was the Company's
accounting and valuation of free standing and embedded derivative instruments
associated with the Company's secured convertible debentures (the "Convertible
Debentures").
On or about August 9, 2006, the Company determined, after discussions with
the SEC and the Company's independent registered accounting firm, to restate its
condensed consolidated financial statements included in Form 10-QSB as of and
for the three month period ended March 31, 2006. The Company originally
estimated the fair value of embedded derivatives using the Black-Scholes option
valuation model. As a result of the aforementioned Comment Letter, the Company
has determined a more comprehensive valuation model is required to properly
estimate the fair value of the embedded derivatives. The Company has employed a
third party valuation firm to estimate the fair value of the free standing and
embedded derivatives and will restate its condensed consolidated financial
statements included in Form 10-QSB as of and for the three month period ended
March 31, 2006 as soon as practicable. The Company believes the adjustments will
not change the loss from operations and will reduce the previously reported
derivative instrument expense and derivative instrument liability. In addition,
the Company believes the adjustments will have no impact on the cash flows of
the Company.
2
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
NEWGEN TECHNOLOGIES, INC.
Dated: August 15, 2006 By: /s/ Scott Deininger
------------------------------
Name: Scott Deininger
Title: Chief Financial Officer
3